Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;102-B(2):148-154.
doi: 10.1302/0301-620X.102B2.BJJ-2019-1104.R1.

Rogue stem cell clinics

Iain R Murray  1 , Jorge Chahla  2 , Rachel M Frank  3 , Nicolas S Piuzzi  4 , Bert R Mandelbaum  5 , Jason L Dragoo  6 ; Members of the Biologics Association
Collaborators, Affiliations

Rogue stem cell clinics

Iain R Murray et al. Bone Joint J. 2020 Feb.

Abstract

Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. Such providers have been known to recommend, prescribe, or deliver so called 'stem cell' preparations without sufficient data to support their true content and efficacy. In this annotation, we outline the current environment of stem cell-based treatments and the strategies of marketing directly to consumers. We also outline the difficulties in the regulation of these clinics and make recommendations for best practice and the identification and reporting of illegitimate providers. Cite this article: Bone Joint J 2020;102-B(2):148-154.

Keywords: Biologics; Direct to consumer marketing; Regulation; Stem Cells.

PubMed Disclaimer

References

    1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813–1826. - PubMed
    1. Armitage JO. Bone marrow transplantation. N Engl J Med. 1994;330(12):827–838. - PubMed
    1. No authors listed Autologous blood stem cell transplantation in acute myeloid leukaemia. Lancet. 1988;1(8582):419–420. - PubMed
    1. LaPrade RF, Dragoo JL, Koh JL, Murray IR, Geeslin AG, Chu CR. AAOS research symposium updates and consensus: biologic treatment of orthopaedic injuries. J Am Acad Orthop Surg. 2016;24(7):e62–78. - PMC - PubMed
    1. LaPrade RF, Geeslin AG, Murray IR, et al. . Biologic treatments for sports injuries II think tank-current concepts, future research, and barriers to advancement, Part 1: Biologics overview, ligament injury, tendinopathy. Am J Sports Med. 2016;44(12):3270–3283. - PubMed

MeSH terms